Search Results 711-720 of 91045 for Metastasis

1. Publications - Umair Majeed, M.B.B.S., M.D. - Mayo Clinic

   ... metastases in the United States? ... Epub 2024 Apr 18. View PubMed; Anisetti B, Ahmed AK, Coston T, Gardner L, Majeed U, Reynolds J, Babiker H. Delayed brain ...

2. Brain tumor - Doctors and departments - Mayo Clinic

   Staff skilled in dozens of specialties work together to ensure quality care and successful recovery. Departments that treat this condition. Brain Metastases ...

3. A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

   Clinical Trials · A Study of Mogamulizumab Combined with Nivolumab in Patients who have Locally Advanced or Metastatic Solid Tumors · More about research at Mayo ...

4. A Study to Assess the Effectiveness and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

   A Study to Assess the Effectiveness and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer.

5. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   ... Metastatic Solid Tumors. Print details. Share; Facebook · Twitter. Overview ... aspartate aminotransferase AST (SGOT) ≤ 3 x ULN (≤ 5 x ULN when HCC or hepatic ...

6. Brain tumor - Doctors and departments - Mayo Clinic

   D. Neurologist. Phoenix, AZ. Areas of focus: Meningioma, Brain tumor, Brain metastasis, Glioma, Acoustic neuroma, Neurofibromatosis, Pituitary tumor ...

7. Fam-trastuzumab deruxtecan-nxki (intravenous route) - Side effects & uses - Mayo Clinic

   ... metastatic or unresectable breast cancer in patients who have previously received an anti-HER2 breast cancer treatment for metastatic disease or have breast ...

8. A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

   Clinical Trials · A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers · More about research at Mayo Clinic · Mayo Clinic Footer.

9. A Study To Evaluate The Adverse Events, And Efficacy Of Intravenous (IV) Of Telisotuzumab Adizutecan In Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab In Adult Participants With Metastatic Colorectal Cancer - Mayo Clinic

   ... Metastatic Colorectal Cancer ... * History of other malignancies within 5 years prior to screening, except for malignancies with a negligible risk of metastasis ...

10. A Pilot, Randomized, Open-label Study of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Pembrolizumab for First Line Treatment of Advanced or Metastatic Non-small Cell Lung Cancer - Mayo Clinic

    ... Metastatic Non-small Cell Lung Cancer. Print details. Share; Facebook ... Has an extrathoracic metastasis (i.e., M component is M1b or M1c). Has an ...